BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Daiichi Sankyo
Chinese Patent Office

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,124,304

« Back to Dashboard

Summary for Patent: 6,124,304

Title: Penciclovir for the treatment of zoster associated pain
Abstract:A method for the treatment of ZAP, in particular PHN, in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of penciclovir or famciclovir, or a pharmaceutically acceptable salt thereof.
Inventor(s): Boon; Ronald James (Dorking, GB), Griffin; David Ronald John (Bishop's Stortford, GB)
Assignee: SmithKline Beecham PLC (Brentford, GB)
Application Number:09/187,660
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 6,124,304

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9320485Oct 05, 1993
United Kingdom9321255Dec 14, 1993
United Kingdom9326177Dec 22, 1993

International Patent Family for Patent: 6,124,304

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany69430545► Subscribe
Denmark0804199► Subscribe
European Patent Office0735878► Subscribe
European Patent Office0804199► Subscribe
China1135180► Subscribe
China1082816► Subscribe
China1142769► Subscribe
China1084622► Subscribe
Cyprus2375► Subscribe
Canada2179282► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus